Arecaidine but-2-ynyl ester tosylate
Discontinued ProductUnfortunately Arecaidine but-2-ynyl ester tosylate (Cat. No. 0382) has been withdrawn from sale for commercial reasons.
Potent muscarinic agonist, 4.6-fold selective for M2 receptors in the atrium versus those in the ileum.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
References are publications that support the products' biological activity.
Barlow and Weston-Smith (1985) The relative potencies of some agonists at M2 muscarinic receptors in guinea pig ileum, atria and bronchi. Br.J.Pharmacol. 85 437 PMID: 3896364
Moser et al (1989) Structure-activity relationships of new analogues of arecaidine propargyl ester at muscarinic M1 and M2 receptor subtypes. Br.J.Pharmacol. 96 319 PMID: 2924082
View Related Products by Product Action
Keywords: Arecaidine but-2-ynyl ester tosylate, supplier, Muscarinic, agonists, Receptors, Acetylcholine, Ach, butynyl, M2, Receptors, M2, Receptors, Tocris Bioscience
Citations for Arecaidine but-2-ynyl ester tosylate
Citations are publications that use Tocris products.
Currently there are no citations for Arecaidine but-2-ynyl ester tosylate.
Reviews for Arecaidine but-2-ynyl ester tosylate
There are currently no reviews for this product. Be the first to review Arecaidine but-2-ynyl ester tosylate and earn rewards!
Have you used Arecaidine but-2-ynyl ester tosylate?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.
Learning & Memory Poster
Recognition memory enables us to make judgements about whether or not we have encountered a particular stimulus before. This poster outlines the cellular mechanisms underlying recognition memory and its links to long-term depression, as well as the use of pharmacological intervention to assess the role of neurotransmitters in recognition memory.
Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.